chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started with COVID-19 symptoms on 8/3/22  including fever, chills, headache, fatigue, muscle aches, and nasal congestion.
After receiving the Shingrix vaccine yesterday, I had chills in the night, woke up this morning with a fever of 100.2 (normal for me is around 96.2) and had a fever throughout the day that went as high as 100.8.  Was completely lacking in energy, requiring bed rest most of the day and 3 naps. Tried to go on a walk this evening as my fever was gone, but only made it one block before needing to go back home and back to bed. Hoping to sleep well tonight and feel much better tomorrow.
Received vaccine on Jan. 30, 2006 on Feb. 19 began having double vision in the left eye and has a tentative diagnosis of optical neuritis. He will be having an mri next week and lab work.
The patient was 11 at the time of injection and the mother lied to get her son an adult dose per her own admission on 7/22/22 when she came to get him his 4th shot/2nd booster and we told her that he is not eligible.
Horrible chills that night starting at 2am, along with body and muscle aches in both arms and shoulders. Next day the muscle aches were all over but not as bad, but a severe headache all day. Treated with tylenol all day along with ibuprofen + tylenol at night. The next day I felt fine, however noticed a baseball sized lump under my left armpit about 60 hours after the shot in my left shoulder. Internet says it's a swollen lymph node and known side effect. The next morning the swelling went down significantly and after another day it seems to be getting better.
Five days after receiving the vaccine I experienced fluttering in my chest and shortness of breath. I experienced these symptoms for approximately one month.  I did not have a cough or any mucus. It seemed difficult to identify why I was feeling this way. I went running approximately a week after my symptoms began and tasted blood while I was running.  I run semi frequently and have never experienced that symptom with exercise.
Fever (101.5); swollen eyelids; red eyes; yellow gook in eyes; sinus pain; neck and mouth glands swollen; cough; sneezing; headache. Eventually improved towards dawn hours.
shortness of breath.  Then had EKG and other cardio work ups.  Slightly abnormal EKG.  I have never ever had a health issue in my life. And never shortness of breath.
Headaches; Rigors; Extreme fatigue; left arm pain radiating up to neck and skull; left arm pain radiating up to neck and skull; chest and back pain /stabbing pain in my left chest; chest and back pain; Nausea; heart palpitations; feeling of impending doom; This is a spontaneous report from a non-contactable nurse, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 18Jan2021 07:30 (at the age of 41-years) to as a single dose for Covid-19 immunization. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Historical vaccine data included that the patient received the first dose of BNT162B2 on 28Dec2020 at 07:15 (at the age of 41-years) in the left arm for Covid-19 immunization. There were no concomitant medications. On 18Jan2021 22:30, 15 hours after second injection the patient experienced symptoms which would best be described as a cardiac event. The patient elaborated that she woke from sleep with left arm pain radiating up to neck and skull, chest and back pain, nausea and stabbing pain in my left chest. This was associated with heart palpitations and a feeling of impending doom. The episode lasted 15 minutes and happened 4 times throughout the night. On 19Jan2021 at 07:30, 24 hours after injections the patient experienced headaches and rigors began with extreme fatigue. Unable to function type of fatigue. Fatigue persisted for 48 hours post injection. The patient was now 72 hours post injection and continued with headache and nausea. The patient did not receive any treatment for the events. The patient had not been tested post vaccination. The clinical outcome of event extreme fatigue, chest and back pain, heart palpitations feeling of impending doom, left arm pain radiating up to neck and skull and rigors was recovering. The outcome of events headaches and nausea was not recovered.  No follow-up attempts are possible; information about lot number cannot be obtained.
pain for 3 months in left shoulder. no treatment, pain finally went away after 3 months.
Several hours after receiving influenza vaccine noticed hives to bilateral inner thighs, posterior neck, bilateral axilla, buttock, bilateral wrist, posterior right knee. Was treated in ED with BENADRYL and SOLU MEDROL.
This spontaneous prospective pregnancy report as received from a Medical Assistant refers to a female patient of unknown age. Medical history, current conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular (Lot # and expiration date were not provided). On an unspecified date, the patient became pregnant. The LMP and EDD were not known. The pregnancy outcome was unknown. Additional information has been requested.
BlurredVision, Myalgia & Syncope Narrative: Employee reports: "I took off work for one and half hours" I'm fine today.
Shingrix unapproved diluent/ shingrix dose reconstituted with saline solution and not with the correct; shingrix dose reconstituted with saline solution and not with the correct; This case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 53-year-old male patient who received Herpes zoster (Shingrix) (batch number 3R45T, expiry date 17th September 2022) for prophylaxis.   On 13th September 2021, the patient received Shingrix. On 13th September 2021, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The pharmacist reported that a male patient received a shingrix dose reconstituted with saline solution and not with the correct diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter consented to follow up.
breaking out on the skin/ the pain on the skin; breaking out on the skin/ the pain on the skin; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's wife) reported a male patient of an unspecified received bnt162b2 (), via an unspecified route of administration from Jan2021 at a single dose for Covid-19 immunization.  The patient medical history and concomitant medications were not reported. The patient got the vaccine yesterday and he is experiencing breaking out on the skin. Her husband already took diphenydramine yesterday, which is an antihistamine to reduce the pain on the skin. His doctor advised not to take the second dose of the vaccine. She is asking if he can take the second dose. She knows two doses are needed of the vaccine, she is asking what his other option would be. Outcome of the events was unknown.  Information on the lot/ batch number has been requested.
Information has been received from a RN concerning a 7 year old while male who on 21May1998 was vaccinated with a first dose of varicella virus vaccine live (lot 622850/0537E) (SC). Subsequently, the pt developed a mild to moderate case of chickenpox on an unspecified day in Apr 2004. The pt recovered. No product quality complaint involved. The registered nurse also reported on two other pt's who had a similar experience after being vaccinated with varicella virus vaccine live (WAES0404USa02232 and 0404USa02308). Additional information has been requested.
patient was only 17 years old when received vaccine. Spoke with father and reported no issues or adverse outcomes with the vaccine
Patient received immunization, walked to the observation chair, and then experienced a vasovagal episode and fell to the floor.  EMS was called. Blood pressure, O2 sats, blood glucose were all within normal limits.
Nurse practitioner reporting an expired dose of Menveo was administered on 05/16/2023. Dose expired on 04/30/2023.; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA710A, expiry date 30-APR-2023) for prophylaxis.   On 16-MAY-2023, the patient received Menveo. On 16-MAY-2023, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Nurse practitioner reporting an expired dose of Menveo was administered on 05/16/2023. Dose expired on 04/30/2023.). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 23-MAY-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. The reporter reported that an expired dose of Menveo was administered, which led to expired vaccine used.
Cough, diarrhea, back pain, fever, strong headache, chills, loss of taste, nose bleed, bruises, pain in jaw, teeth, eye pressure, severe pain in neck.
Received immunizations 10-7-10 at 12:50 pm, pt reported onset at 7pm that evening. "Sunburned feeling to tops of arms & nausea". Pt called us at 8:45 am on 10-8-10. Pt was in touch with her MD's office & took dose of O.T.C. BENADRYL. Called pt back at 12:15 pm stated "I'm feeling better". Followed up via phone 10-21-10 at 2pm pt reported full recovery with no MD visits needed.
Patient received Johnson & Johnson vaccine on 4-5-21 and again on 11-4-21 so this third Moderna dose was an erroneous one
Pt exp sudden diarrhea, low grade temp, loss of appetite, exhaustion, weight loss & inability to function on 29MAR92; 3 days p/2nd dose 26APR92 pt exp no sx following dose of 2 Engerix-B
Information has been received from a consumer concerning her 11 year old daughter who on 20-AUG-2009 was vaccinated with the first dose of GARDASIL (Lot number not provided). Secondary suspect therapy included hepatitis A virus vaccine inactivated (manufacturer unknown). Concomitant vaccinations included tetanus toxoid (unspecified) and meningococcal vaccine (unspecified). Subsequently on 27-AUG-2009 the patient developed hives that were itchy and looked like bug bites on her legs and stomach and recently the patient started to have some lip swelling. The patient's mother reported that the patient was going to see an allergist but has not yet recovered. The patient sought medical attention. Follow up information has been received from the physician concerning the patient who was vaccinated with the first dose of GARDASIL (IM) lot# 663451/0261Y) on 20-AUG-2009. The patient's father stated that the patient had hives around the time of the vaccination. On 03-NOV-2009, the patient was vaccinated with the second dose of GARDASIL and there were no problems. At the time of the report, the patient had recovered on an unspecified date. No further information is available.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients had no pertinent medical history, concurrent conditions or concomitant therapies reported. On unspecified dates, the patients received an improperly stored dose of GARDASIL 9 ( lot # M009378; expiration date 23-APR-2018 (dose number and route of administration were not provided). No adverse effects were reported. The administered vaccines experienced a temperature excursion of 34.3 degree F for 1 hour on an unspecified date. Data logger was not involved. There was not product quality complaint involved. Additional information has been requested.
Six of the patients developed shingles within several days of receiving the vaccine; This is a spontaneous report from a contactable consumer. This consumer reported similar event for six patients. This is second of six report. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced six of the patients developed shingles within several days of receiving the vaccine. Reported that reporter read on the internet an article published specifically on  The researchers found that six of the patients developed shingles within several days of receiving the vaccine. All of the patients were women, and five of the reactions happened after the first vaccine dose. The RA also said that it's triggered by the same virus that causes chickenpox." She is asking if she should take a Shingles shot before getting the vaccine. She is surprised that we don't have any data on shingles or herpes since the Pfizer-BioNTech COVID-19 Vaccine was linked in the article and people have reported these and her daughter also experienced it. The outcome of event was unknown.  Information on batch/lot number has been requested.
Fever, congestion, migraines, fatigue, body aches, and diarrhea
He is been throwing up, he has been vomiting/vomiting in every half an hour or every hour; Nauseous; This is a spontaneous report received from a contactable reporter (Consumer).  A male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 13:00 (Lot number: EN6205) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 04Mar2021 18:00, outcome "unknown", described as "Nauseous"; VOMITING (non-serious) with onset 04Mar2021 21:00, outcome "unknown", described as "He is been throwing up, he has been vomiting/vomiting in every half an hour or every hour".  Additional information: he is like vomiting in every half an hour or every hour.  No follow-up attempts are possible. No further information is expected.
Wheezing, cough, throat soreness, chest congestion, fatigue  Tylenol
Had Lyme disease since 7/95-9/95, dormant until  6/96, returned 11/97, dormant until 5/7/98, returned 10/98, dormant until 2/17/99, never took more than 6 wks to be nml. Took Doxycycline x 3, Biaxin x 2. Post/vax 4/8/99, sx's worse. FU notes that pt has been dxed with spinal arthritis and continues with neck and headaches every day. Annual follow-up states the pt has knee pain and vision problems due to the vaccine.
9 year old pt came in to update immunizations. Pt had received 4 DTaP's (last was given at 1 yrs of age). Pt then received 5th dose of DTaP in clinic.
The patient received the vaccines at 1PM. She called the pharmacy around 4:30pm and talked to RPh. She said her throat felt scratchy and wanted to know if the vaccines could have caused this reaction. He asked about any other symptoms. She said her throat was the only this bothering her. She did not have any itching  or  SOB.  He advised her to take some Benadryl and go to the ER if her symptoms did not improve. The next day she came to the pharmacy with an RX for Prednisone. She said she got worse and called 911. She went by ambulance to the ER on the evening that she got the vaccines. She was treated for an allergic reaction at the ER and given an RX for Prednisone, Zyrtec, and Zaditor.  She has gotten the flu shot many times in the past and so she believes the Prevnar 13 is the cause of the reaction.  I spoke with her this morning and filled her RX for Prednisone. She says that all her symptoms have gone away except that her throat still feels like there is something stuck in it and is hard to swallow.
March 2021 blood pressure continued to be kind of high and low. Statin medications I went to the ER one night my blood pressure was 200/100. I was there for 3-4 hours. They sent me home. 3 weeks later I was in grocery store with my husband back by the bakery I felt my heart flipping. I became very lightheaded I lend on the shopping cart and walked myself to the front of the store. 911 was called but an ambulance was out front. My blood pressure was 185/80. I stayed at hospital all day. The blood test determined that there wasn't anything wrong with my heart. I wasn't allowed to have any salt; I was on a Vegetarian diet. I can't seem to gain any weight now. My blood pressure is now 106/80 in morning now which is low but normal. I went back to my original diet now.
This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a 50-year-old male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX (intramuscular) .5 ml. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced pain in arm, influenza-like symptoms and pruritus. The patient was treated with BENADRYL. On an unknown date, the outcome of the pain in arm, influenza-like symptoms and pruritus were unknown. It was unknown if the reporter considered the pain in arm, influenza-like symptoms and pruritus to be related to SHINGRIX. Additional details were provided as follows: This case was reported by medical assistant. The age at vaccination was not reported. The patient received SHINGRIX on the left arm. The patient experienced a sore arm and significant flu like symptoms throughout the day. That evening he also reported itching from head to toe, no rash, and the itching responded to a dose of BENADRYL. The patient reported not taking any other medications or unusual activity that could be related to the itching. The reporter agreed to contact for follow up.
arm was sore at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (arm was sore at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE PAIN (arm was sore at the injection site). At the time of the report, INJECTION SITE PAIN (arm was sore at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
I received the first dose of the Shingrix vaccine yesterday morning at 10:00 a.m. and all seemed fine.  By 4 p.m. I noticed my lower back was feeling sore and by 6 p.m. I was feeling achy all over.  By 9 p.m. I had a fever and some serious chills for about 30 minutes.  I got in bed, took 1 extra-strength Tylenol and finally went to sleep around 11 p.m.  By 2 a.m. the fever seemed to have come down but I took another Tylenol.  I got up around 6:30 this morning and other than feeling tired I seem to be okay now.  My temperature is almost back to normal and I no longer have any aches and pains other than the usual ones. I experienced no congestion in my chest, sinuses or ears nor sore throat.  There's no rash or more than expected soreness at the injection site in my arm.  It was just maybe 8-10 hours of a nasty fever and chills and then I was over it.
Began itching in ears, nose & throat. Then became short of breath and went to the ED. Eyes were swelling.
This spontaneous report was received from a physician concerning 2 patients who on unknown dates were vaccinated with a dose of VARIVAX (Merck) (dose, route and lot # not provided). On unknown dates, the patients were diagnosed with the varicella virus after receiving the VARIVAX (Merck) vaccine. The patient visited the emergency room for treatment and were not admitted. On unknown dates, the patients recovered from the event. The relatedness for the event was unknown for VARIVAX (Merck). Additional information has been requested.
Tinnitus; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TINNITUS (Tinnitus) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (Tinnitus). At the time of the report, TINNITUS (Tinnitus) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment medication was not provided.   This case was linked to MOD-2021-066184, MOD-2021-066184 (Patient Link).
In Feb of 2023, the afternoon of the 13th I started to feel something coming on. By the next afternoon I felt feverish and taking my temp confirmed it. I called to reschedule an ENT appt for the next day and to schedule an appt with Dr. At the appt I tested negative for Covid and the flu. They did an MRI of my chest to make sure it wasn't pneumonia and listened to my heart and did my blood pressure and then Rx'd a z-pac and cough syrup. Monday (a holiday) I still felt terrible and decided to check my bp. It was 90/53! Time for the ER! Feb 19:  Not only was my bp low, I was in atrial fibrillation. Lots of things done for me to stabilize me. They kept me overnight for observation and released me the next morning.
The patient received the Moderna COVID-19 vaccine 4 days beyond the recommended expiration date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received the Moderna COVID-19 vaccine 4 days beyond the recommended expiration date.) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: J&J vaccine (Batch no-1805018, Dose-0.5 ml, Route-Intramuscular and Body site-arm) on 24-Jan-2021. Past adverse reactions to the above products included No adverse event with J&J vaccine.    On 24-Jan-2022 at 8:33 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 24-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received the Moderna COVID-19 vaccine 4 days beyond the recommended expiration date.). On 24-Jan-2022, EXPIRED PRODUCT ADMINISTERED (The patient received the Moderna COVID-19 vaccine 4 days beyond the recommended expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (The patient received the Moderna COVID-19 vaccine 4 days beyond the recommended expiration date.) to be not related.    As per Moderna, the vaccine will maintain the necessary effectiveness against COVID-19. Concomitant drugs were not reported.Treatment details were not given   This case was linked to MOD-2022-460301 (Patient Link).
Yesterday around 11am noticed swollen on top of left hand continued to swell for about an hour. Size of half tennis ball between wrist and knuckles. Put ice on it then went to see doctor. Sensitive to touch after doctor and nurse poked it. Later had difficulty closing my hand due to the swelling around 3pm. Today swelling has gone down.